Work

Targeting LMTK3 in ovarian cancer: A dual role in prognosis and therapy

Year: 2024

Type: article

Abstract: Ovarian cancer (OC) remains one of the most lethal gynecological cancers, with limited treatment options, particularly for recurrent disease. To combat this, recent research has focused on identifying molecular drivers that could serve as novel therapeutic targets. In this context, Saed et al. present compelling evidence positioning lemur tail kinase 3 (LMTK3) as both a prognostic biomarker and a prospective novel therapeutic target in OC.1 Their study revealed that LMTK3 is expressed in >98% of early-stage OC tumor tissues (n = 204).

Source: Molecular Therapy Oncology

DOI: 10.1016/j.omton.2024.200902

Authors: Chrysa Filippopoulou, Georgios Giamas

Institutions: Zhejiang Chinese Medical University, University of Sussex

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,900